Print

Print


Daily News - Philadelphia
Monday, June 18, 2001
Editorial 
Politics vs: Science in White House
Stem Cell Research Could Aid in War on Disease
Last summer, we applauded the National Institutes of Health decision
to allow federally funded scientists to work on stem cells taken from
human embryos.

Because virtually any kind of cell - muscle, fat, even nerve - can grow
from them, stem cells could lead to effective new treatments for
Parkinson's disease, spinal cord injuries and a variety of other
conditions, including Alzheimer's. The NIH policy, signed by
President Bill Clinton, was a balanced one that responsibly addressed
the ethical issues involved.

Stem cells would come only from embryos, destined to be discarded,
that are obtained in fertility clinics by mixing sperm and eggs.

The policy also placed stringent constraints on who could remove
the stem cells, would forbid profiteering by the couple in question
or other relatives, would identify the source of the embryo, and
would require oversight by four different committees during the
review process.

Unfortunately, these constraints were not enough for the Bush
administration. Health and Human Services Secretary Tommy
Thompson has suspended the guidelines pending further review.
Thompson has promised to decide by this summer whether to
permit such research to continue.

As is increasingly common with the Bush administration,
science and politics are at odds.

Many groups have approved the research (subject to reasonable
conditions), and 80 Nobel laureates have asked the president to
continue funding embryonic cell research. Yet, the recommendations
are being held hostage by Bush adviser Karl Rove. No expert on the
science or the ethics of the issue, Rove worries only about the
reaction of Bush's conservative base and the anti-abortion forces.

Selfishly, the Bush team values those votes over the well-being
of others.

Also a neophyte on these matters, Bush has said he would not
object if the stem cells were taken from adults. Of course, this is
unlikely to be very helpful since most scientists doubt that adult
cells have the same versatility.

NIH adopted a sensible policy on stem cell research. Let's hope
that political considerations don't lead instead to one that is, in
effect, pro-Parkinson's, pro-paraplegia, pro-Alzheimer's. *

http://dailynews.philly.com/content/daily_news/2001/06/18/opinion/EDT
A18E.htm

*********

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn